Publication: Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab
| dc.contributor.author | S. Hongeng | en_US |
| dc.contributor.author | P. Tardtong | en_US |
| dc.contributor.author | S. Worapongpaiboon | en_US |
| dc.contributor.author | A. Ungkanont | en_US |
| dc.contributor.author | S. Jootar | en_US |
| dc.contributor.other | Mahidol University | en_US |
| dc.date.accessioned | 2018-07-24T03:10:52Z | |
| dc.date.available | 2018-07-24T03:10:52Z | |
| dc.date.issued | 2002-01-01 | en_US |
| dc.description.abstract | Here, we report a case of paediatric β-thalassaemia major patient who underwent unrelated T cell-nondepleted bone marrow transplantation and developed a complication of autoimmune haemolytic anaemia (AIHA) refractory to corticosteroid and intravenous immunoglobulin therapy. After this child received two doses (375 mg/m2/dose) of rituximab (anti-CD20 monoclonal antibody), his AIHA was resolved. | en_US |
| dc.identifier.citation | Bone Marrow Transplantation. Vol.29, No.10 (2002), 871-872 | en_US |
| dc.identifier.doi | 10.1038/sj.bmt.1703551 | en_US |
| dc.identifier.issn | 02683369 | en_US |
| dc.identifier.other | 2-s2.0-0035998368 | en_US |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/123456789/20569 | |
| dc.rights | Mahidol University | en_US |
| dc.rights.holder | SCOPUS | en_US |
| dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0035998368&origin=inward | en_US |
| dc.subject | Medicine | en_US |
| dc.title | Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0035998368&origin=inward | en_US |